PT-141, derived from Melanotan II, was specifically developed to enhance sexual arousal and is now FDA-approved for treating hypoactive sexual desire disorder (HSDD) in premenopausal women
This suggests its due to the body adjusting to the drug and possibly quick weight loss
In dermaroller with copper peptide group, those under 25 years of age had a mean baseline score of 20, decreasing to 14 at the final follow-up, whereas those above 25 years had a mean baseline score of 23, decreasing to 18 at the final follow-up
Studies show that Glp1r agonists either increase [1719] decrease [20, 21], or do not influence [8, 2224] EE
This dual-action medication provides unmatched benefits for individuals looking to manage their blood sugar and achieve lasting weight loss results